Pradžia › Ūmi bifeninė leukemija › New York

Ūmi bifeninė leukemija klinikiniai tyrimai New York

11 tyrimai dėl Ūmi bifeninė leukemija ieško dalyvių vietose New York.

Miestai New York

Oficialus tyrimo tekstas (anglų kalba)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Memorial Sloan Kettering Cancer Center, New York

Renkami dalyviai1 fazė

Amžius nuo 12 iki 78 · Visoms lytims · Atnaujinta 2026-09-29 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Albany Medical Center, Albany
Roswell Park Cancer Institute, Buffalo
The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
ir dar 7

Renkami dalyviai2 fazė

365 Days · Visoms lytims · Atnaujinta 2026-09-25 · NCT06317662

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Montefiore Medical Center, New York

Renkami dalyviai1/2 fazė

30 Days · Visoms lytims · Atnaujinta 2026-09-16 · NCT04065399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
Roswell Park Cancer Institute, Buffalo
ir dar 12

Renkami dalyviai3 fazė

365 Days – 25 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
NYU Langone Hospital - Long Island, Mineola
ir dar 7

Renkami dalyviai1/2 fazė

Iki 22 metų · Visoms lytims · Atnaujinta 2026-08-25 · NCT04726241

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

New York Medical College, Valhalla

Renkami dalyviai1/2 fazė

Amžius nuo 13 iki 90 · Visoms lytims · Atnaujinta 2026-08-06 · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Memorial Sloan- Kettering Cancer Center, New York

Renkami dalyviai1 fazė

Amžius nuo 1 iki 30 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06177067

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Weill Cornell Medicine - New York Presbyterian Hospital, New York

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-07 · NCT07216443

A Study of Revumenib and Mezigdomide in People With Leukemia

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
ir dar 1

Renkami dalyviai1/2 fazė

Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-06-22 · NCT07356154

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

Memorial Sloan Kettering Cancer Center, New York

Renkami dalyviai1 fazė

Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-01-08 · NCT04872478

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Children's Hospital New York-Presbyterian, New York
Memorial Sloan Kettering Cancer Center, New York

Renkami dalyviai1 fazė

Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2024-12-06 · NCT05476770

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.